Neuropatía óptica por etambutol en paciente con esclerosis múltiple

  1. V. Gómez Calleja 1
  2. P. Pérez García 1
  3. F. Ly Yang 1
  4. E. Santos Bueso 1
  1. 1 Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
    info

    Instituto de Investigación Sanitaria del Hospital Clínico San Carlos

    Madrid, España

    ROR https://ror.org/014v12a39

Journal:
Archivos de la Sociedad Española de Oftalmologia

ISSN: 0365-6691

Year of publication: 2022

Volume: 97

Issue: 1

Pages: 52-57

Type: Article

DOI: 10.1016/J.OFTAL.2020.12.009 DIALNET GOOGLE SCHOLAR

More publications in: Archivos de la Sociedad Española de Oftalmologia

Sustainable development goals

Abstract

We present the clinical case of a patient who developed a toxic optic neuropathy due to ethambutol in the context of a tuberculosis reactivation and who also had a personal history of multiple sclerosis. The objective is to highlight the importance of making a good differential diagnosis of this adverse effect and of knowing its main clinical, campimetric and tomographic manifestations and characteristics. Furthermore, since the reversibility of damage is still discussed in the literature, early diagnosis is essential. For this purpose, it is important to inform the patient of the possible symptoms and to carry out an ophthalmological examination and colour tests before starting treatment to assess whether there is progression.